Streetwise Reports' Article Archives — March 2020 back to current month (43)
Sproutly Canada's subsidiary company Toronto Herbal Remedies has entered into a cannabis supply contract with Manitoba and Saskatchewan provinces to carry the firm's CALIBER brand indoor-grown dried flower products.
Shares of Kiniksa Pharmaceuticals traded higher after the company reported early success in treatment response for mavrilimumab in six patients with severe COVID-19 pneumonia and hyperinflammation.
Shares of Abbott Laboratories opened 11% higher after the company reported that its ID NOW™ molecular point-of-care test to detect novel coronavirus will be available starting this week with plans to quickly ramp up production to deliver 50,000 tests per day.
Shares of Eton Pharmaceuticals traded higher after the company reported that it has acquired U.S. marketing rights to pediatric orphan drug Alkindi® Sprinkle from Diurnal Group Plc.
This new market is a significant one for Avivagen.
Nu-Med Plus has two collaborative, Phase 2 clinical trials in progress, which it is diligently monitoring.
ParcelPal Technology continues expanding its reach into this growing market.
Coronavirus Propels Telemedicine into the Spotlight (03/26/2020)
McAlinden Research Partners takes a look at how telemedicine companies are positioned to profit both during and in the wake of the current pandemic, and offers a couple of options for investors.
Reliq Health Technologies has entered into an agreement with MedTech Evolutions to provide its iUGO Care platform to over 27,000 patients in Alabama, Illinois, Mississippi and Tennessee.
Draganfly and its partners aim to rapidly deploy the groundbreaking technology so it can help combat COVID-19.
Shares of Coty traded higher after the company reported that it has commenced production of hydro-alcoholic gel for use as hand sanitizer to help combat the COVID-19 virus.
Biopharma to Accelerate Alzheimer Trial Completion (03/25/2020)
The upcoming catalysts for Axsome Therapeutics and the effects of COVID-19 on its clinical activities are discussed in an H.C. Wainwright & Co. report.
The company plans to accelerate the path to greater revenues and profitability.
Shares of T2 Biosystems Inc. traded 90% higher after the company reported that a new COVID-19 assay licensed from Hackensack Meridian Health's Center for Discovery and Innovation will be adapted to run on its FDA-cleared T2Dx® Instrument.
ParcelPal Technology hired 50 new staff members in order to guarantee that service levels can be maintained without disruption to clients and vendors as the firm faces major increases in demand.
Simple, non-invasive hospital-style wrist band and SaaS technology could spell explosive growth for company as the world combats the coronavirus.
Reliq Health Technologies explains how it is helping protect its customers' elderly patients.
The company anticipates adoption of the TRACEsafe system by other countries soon.
Shares of Bellerophon Therapeutics reached a new 52-week high price after the firm reported that the FDA granted emergency expanded access for its INOpulse® nitric oxide delivery system device for use in treatment of COVID-19 virus.
Avivagen hires a firm to assist with the product's commercial debut.
The firm's three upcoming potential stock movers are reviewed in a ROTH Capital Partners report.
iBio Inc. shares traded higher after the company reported that it has filed several provisional patents for its SARS-CoV-2 Virus-Like Particle platform with the U.S. Patent and Trademark Office.
Shares of Regeneron Pharmaceuticals rose to a new 52-week high price after the company reported it has identified hundreds of virus-neutralizing antibodies and plans to initiate large-scale manufacturing by mid-April of a multi-antibody therapy to treat coronavirus.
CloudMD reported it will offer free-trial telemedicine solutions to healthcare professionals across North America to help manage the coronavirus pandemic.
ParcelPal Technology reported that it has signed an agreement to deliver pharmaceuticals and Covid19 supplies including test kits in three areas of Canada with the potential of reaching more than 40 pharmacies nationwide.
OPKO Health shares traded more than 30% higher after the company reported its subsidiary BioReference Laboratories has formed a partnership with the N.Y. State Department of Health to provide COVID-19 testing for the first public drive-through testing facility on the East Coast.
Shares of Predictive Oncology traded higher after the company reported that it launched a new AI vaccine and drug development platform targeting coronaviruses and acute respiratory syndromes and that it is acquiring Soluble Therapeutics assets including its HSC Technology.
Imagin Medical announced on-going research feedback on its i/Blue™ Imaging System which allows simultaneous viewing of white and blue light images during bladder cancer resection procedures.
Vir Biotechnology shares traded higher after the company reported that it has entered into a research collaboration with the National Institutes of Health Vaccine Research Center on antibodies against coronaviruses including SARS-CoV-2.
Aytu BioScience shares rose by more than 750% at times today after the company reported that it secured an exclusive U.S. distribution agreement for COVID-19 point-of-care Rapid Test from a Hong Kong firm.
Shares of AIM ImmunoTech traded more than 150% higher after the company reported that Japan's National Institute of Infectious Diseases will test its Ampligen® drug as a potential treatment for the coronavirus.
CloudMD reported it's accelerating onboarding of physicians amid rising COVID-19 concerns. The firm also advised it is on track to close a new CA$3 million brokered financing on March 11, 2020.
U.S.-Based Biotech 'Growing into a Giant with AI' (03/07/2020)
How Moderna uses and benefits from digitization and artificial intelligence are described in a ROTH Capital Partners report.
Shares of Enzo Biochem traded higher after the company advised that they will launch coronavirus testing services starting next week.
Webcast will be at 12 noon ET on Friday, March 6.
The reasons Forty Seven attracted a buyer and its near-term catalysts are provided in a BTIG report.
CloudMD announced it will be installing proprietary kiosks in participating pharmacies to enable on-demand telemedicine visits with licensed physicians.
Ocular Therapeutix shares set a new 52-week high price after the company reported preliminary FY/19 revenue results along with positive interim data from its Phase 1 clinical study of OTX-TKI for treatment of wet age-related macular degeneration.
Reliq Health Technologies reported that it has signed a contract with Blum Telehealth to provide its iUGO Care software platform to over 50,000 Medicare patients in the state of Louisiana.
Shares of GenMark Diagnostics traded higher after the firm reported FY/19 financial results and announced that it has increased global shipment of its test kits designed to detect the SARS-CoV-2 virus.
CloudMD will be scaling up its freely accessible telemedicine app that allows patients to see a doctor in real-time using either a smartphone or desktop device.
Reliq Health Technologies will provide its software and call center support.
Karyopharm Therapeutics shares set a new 52-week high price after the company reported that its Phase 3 BOSTON trial of XPOVIO® achieved significant increases in progression-free survival in patients suffering with multiple myeloma.
|"PMN's upside is relatively unlimited; it is rated an Immediate Buy."|